News

Press Releases
Kane Biotech – Q1 2017 Financial Results

WINNIPEG, Manitoba – (Marketwired – May 17, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q1 2017 Financial Results.

Highlights:

Total Revenue during the quarter ended March 31, 2017 was $784,900, an…

> Read More

Press Releases
Kane Biotech – Business and Intellectual Property Update

WINNIPEG, Manitoba – (Marketwired – May 11, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to provide an update on its business activities and intellectual property achievements.

The Corporation continues to focus the majority of…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – March 27, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on March 27, 2017, it issued 80,251 common shares of the Corporation (“Common Shares”) in payment of $12,439 in interest owing on the Corporation’s $500,000…

> Read More

Press Releases
Kane Biotech Announces Completion of Share Consolidation

WINNIPEG, Manitoba – March 10, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that, further to the approval by the Corporation’s shareholders obtained on December 16, 2016, the Corporation has completed the consolidation of its…

> Read More

Press Releases
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra

WINNIPEG, Manitoba – March 6, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce that it has entered into an exclusive license and distribution agreement (the “License Agreement”) with Dechra Veterinary Products LLC (“Dechra”),…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – December 21, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on December 21, 2016, it issued 251,385 common shares of the Corporation (“Common Shares”) in payment of $12,569 in interest owing on the Corporation’s $500,000…

> Read More

Press Releases
Kane Biotech Announces Results of Special Meeting and Proposed Share Consolidation

WINNIPEG, Manitoba – December 16, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that a special resolution of the shareholders of the Corporation was passed at the special meeting of shareholders of the Corporation held…

> Read More

Press Releases
Kane Biotech Announces Shareholder Meeting to Consider Share Consolidation

WINNIPEG, Manitoba – November 25, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has sent a notice of meeting, management information circular, proxy and related materials (the “Meeting Materials”) to its shareholders…

> Read More